ImmunologybioRxivPreprint
ERK5 is required for neutrophil-mediated ROS release and essential in epidermolysis bullosa acquisita
Sören Dräger, Mareile Schlotfeldt, Leonie Caroline Voß…·Katja Bieber
This study shows ERK5 inhibition reduces neutrophil ROS release and ameliorates EBA, suggesting ERK5 as a therapeutic target in ROS-driven autoimmune diseases.
1 citation